Brief: Quantum Biopharma Announces Positive Results Of The Clinical Study Report (CSR)
05/08/2025 13:37
Aug 5 (Reuters) - Quantum Biopharma Ltd QNTM.CD: QUANTUM BIOPHARMA ANNOUNCES POSITIVE RESULTS OF THE CLINICAL STUDY REPORT (CSR) FOR THE PHASE 1 MULTIPLE ASCENDING DOSE (MAD) CLINICAL TRIAL OF EXPERIMENTAL MULTIPLE SCLEROSIS DRUG LUCID-21-302 (LUCID-MS) QUANTUM BIOPHARMA LTD - CSR FINDS NO SAFETY CONCERNS FOR LUCID-MS Source text: ID:nGNX4GhqZg Further company coverage: QNTM.CD ((Reuters.Briefs@thomsonreuters.com;))